BioPharma Dive – AI / Data

AstraZeneca to boost cell therapy capabilities with new China investment

Published

3 weeks ago

on

The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version